Category: u.s. stock market today

Stubhub eyes IPO by late summer, The Information Says

 stock analyst  04/13/2024  0 Comments on Stubhub eyes IPO by late summer, The Information Says

Investing.com — StubHub is mulling plans to go public by late summer in an initial public offering that the online ticketing service business hopes will value it at about $16.5 billion, The Information reported Friday, citing unnamed sources.

Why AMD (AMD) Stock Is Nosediving

 stock analyst  04/13/2024  0 Comments on Why AMD (AMD) Stock Is Nosediving

What Happened: Shares of computer processor maker AMD (NASDAQ:AMD) fell 5.1% in the morning session after the Wall Street Journal…

Why Coupang (CPNG) Stock Is Trading Up Today

 stock analyst  04/13/2024  0 Comments on Why Coupang (CPNG) Stock Is Trading Up Today

What Happened: Shares of e-commerce marketplace Coupang (NYSE:CPNG) jumped 11.4% in the afternoon session after the company announced it would…

Key Mining Corp Announces Downsized 4.44M Share IPO at $2.25/sh

 stock analyst  04/13/2024  0 Comments on Key Mining Corp Announces Downsized 4.44M Share IPO at $2.25/sh

Key Mining Corp (KMCM) has filed for a 4,444,444 share IPO at $2.25 per share. The company previously indicated a 7.2M share IPO at same price levels.

U.S. Steel shareholders give greenlight to Nippon Steel's $14.9 billion takeover bid

 stock analyst  04/13/2024  0 Comments on U.S. Steel shareholders give greenlight to Nippon Steel's $14.9 billion takeover bid

(Reuters) – U.S. Steel shareholders voted in favor of the proposed $14.9 billion acquisition by Japan\’s Nippon Steel, moving the merger closer to completion while the deal faces regulatory scrutiny and political opposition.

Goldman Sachs launches coverage on 3 India CRO/CDMO'S

 stock analyst  04/13/2024  0 Comments on Goldman Sachs launches coverage on 3 India CRO/CDMO'S

Goldman Sachs has expanded its coverage to the India CRO/CDMO (contract research organization/contract development and manufacturing organization) space as supply diversification in the global pharmaceutical industry picks up. In a note, analysts initiated coverage on three stocks – two Buys and one Sell.